Abcam is a global life sciences company that develops and delivers high-quality biological reagents and tools that are critical to research, drug discovery and diagnostics

INVESTORS

Abcam to present at Morgan Stanley’s 19th Annual Global Healthcare Conference

PRESS RELEASE

Abcam to acquire BioVision, Inc

PARTNERING

Accelerating discovery of SARS-CoV-2-neutralizing antibodies through synergistic collaboration with Sandia

PRESS RELEASE

Abcam opens new US facility in Boston, MA

REPRODUCIBLE SCIENCE

Abcam joins YCharOS Industry Advisory Committee to further support addressing the life sciences reproducibility crisis

COVID-19

Our business during COVID-19

SUSTAINABILITY

What a pandemic has taught us about our abilities to work remotely and flexibly

Latest events

About us

Driven by our purpose to help accelerate science


We are empowering the global life science and clinical communities. Delivering the next generation tools and solutions that are helping accelerate research, leading to new discoveries with positive impact on society.

OUR PURPOSE

Driven by our purpose to help accelerate science


We are empowering the global life science and clinical communities. Delivering the next generation tools and solutions that are helping accelerate research, leading to new discoveries with positive impact on society.

Discover more